Current Protein Identity:O15381 New Search
Main Difference Dimensions in This Set
Different construct Different mutation/modification Different assembly state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics

Difference tags compare only the current result set; every original PDB and assembly record remains separate.

Related-Structure Differences

Each row represents one biological assembly in one PDB entry; multiple monomers of the same protein are listed separately.

PDB Entry Assembly / Oligomeric State Construct Mutations and Modifications Ligands, Ions and Non-polymers Experimental Method Experimental Conditions Structure Quality
2X8A Human Nuclear Valosin containing protein Like (NVL), C-terminal AAA- ATPase domain Deposited 2010-03-08 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 574–845(272 aa) Fragment:C-TERMINAL AAA-ATPASE DOMAIN, 574-845
Not recorded PO4 PHOSPHATE ION × 2 X-RAY DIFFRACTION mmCIF provides none of the parsed conditions Resolution 2.60 Å R-free 0.250
6RO1 X-ray crystal structure of the MTR4 NVL complex Deposited 2019-05-10 Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain B 167–216(50 aa)
Not recorded SO4 SULFATE ION × 6 ADP ADENOSINE-5'-DIPHOSPHATE × 1 CL CHLORIDE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 8;277 K;0.1M Tris/HCl pH 8.0, 1.8M Ammonium Sulphate
Resolution 3.07 Å R-free 0.257
9BJI Cryo-EM structure of apo NVL Deposited 2024-04-25 Assembly 1 Protein heterocomplex Heteromer;Protein × 7 PDB declaration: heptameric(7) Consistent with protein count
Chain A 1–856(856 aa)
Chain B 1–856(856 aa)
Chain C 1–856(856 aa)
Chain D 1–856(856 aa)
Chain E 1–856(856 aa)
Chain F 1–856(856 aa)
Mutation:E365Q,E682Q Mutation:E365Q,E682Q Mutation:E365Q,E682Q Mutation:E365Q,E682Q Mutation:E365Q,E682Q Mutation:E365Q,E682Q ATP ADENOSINE-5'-TRIPHOSPHATE × 9 MG MAGNESIUM ION × 8 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 2.83 Å
9BJJ Cryo-EM structure of NVL bound the the MM017 inhibitor Deposited 2024-04-25 Assembly 1 Protein heterocomplex Heteromer;Protein × 7 PDB declaration: heptameric(7) Consistent with protein count
Chain A 1–856(856 aa)
Chain B 1–856(856 aa)
Chain C 1–856(856 aa)
Chain D 1–856(856 aa)
Chain E 1–856(856 aa)
Chain F 1–856(856 aa)
Mutation:E365Q, E682Q Mutation:E365Q, E682Q Mutation:E365Q, E682Q Mutation:E365Q, E682Q Mutation:E365Q, E682Q Mutation:E365Q, E682Q ATP ADENOSINE-5'-TRIPHOSPHATE × 9 MG MAGNESIUM ION × 8 A1AP0 N-[10-(2-methoxyethyl)-11-oxo-10,11-dihydrodibenzo[b,f][1,4]thiazepin-7-yl]furan-3-carboxamide × 2 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.06 Å
9NYP Cryo-EM structure of NVL bound the the MM927 inhibitor Deposited 2025-03-28 Assembly 1 Protein heterocomplex Heteromer;Protein × 7 PDB declaration: heptameric(7) Consistent with protein count
Chain A 1–856(856 aa)
Chain B 1–856(856 aa)
Chain C 1–856(856 aa)
Chain D 1–856(856 aa)
Chain E 1–856(856 aa)
Chain F 1–856(856 aa)
Mutation:E366Q,E683Q Mutation:E366Q,E683Q Mutation:E366Q,E683Q Mutation:E366Q,E683Q Mutation:E366Q,E683Q Mutation:E366Q,E683Q ATP ADENOSINE-5'-TRIPHOSPHATE × 9 MG MAGNESIUM ION × 8 ADP ADENOSINE-5'-DIPHOSPHATE × 1 A1B7F N-[10-(but-2-yn-1-yl)-3-fluoro-11-oxo-10,11-dihydrodibenzo[b,f][1,4]thiazepin-7-yl]-3-methyl-2-oxo-2,3-dihydro-1,3-benzoxazole-5-carboxamide × 1 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 2.86 Å